MicroRNA-142-3p inhibits hypoxia/reoxygenation‑induced apoptosis and fibrosis of cardiomyocytes by targeting high mobility group box 1.
about
The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical ApplicationmicroRNA-142-3p inhibits apoptosis and inflammation induced by bleomycin through down-regulation of Cox-2 in MLE-12 cells.Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1MicroRNA as a Therapeutic Target in Cardiac Remodeling.MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation, migration and invasion in cutaneous squamous cell carcinoma.Retinoic acid receptors α and γ are involved in antioxidative protection in renal tubular epithelial cells injury induced by hypoxia/reoxygenation.Stage‑dependent changes of β2‑adrenergic receptor signaling in right ventricular remodeling in monocrotaline‑induced pulmonary arterial hypertension.miR-142-3p regulates autophagy by targeting ATG16L1 in thymic-derived regulatory T cell (tTreg).Inhibition of miR-34a-5p alleviates hypoxia-reoxygenation injury by enhancing autophagy in steatotic hepatocytes.MicroRNA-30e protects the heart against ischemia and reperfusion injury through autophagy and the Notch1/Hes1/Akt signaling pathway.MicroRNA-495 inhibits the high glucose-induced inflammation, differentiation and extracellular matrix accumulation of cardiac fibroblasts through downregulation of NOD1.MicroRNA-381 protects myocardial cell function in children and mice with viral myocarditis via targeting cyclooxygenase-2 expression.Comparative expression analysis identifies the respiratory transition-related miRNAs and their target genes in tissues of metamorphosing Chinese giant salamander (Andrias davidianus).MicroRNA-30b protects myocardial cell function in patients with acute myocardial ischemia by targeting plasminogen activator inhibitor-1.
P2860
Q33624461-926C7967-67E4-4020-A676-5E8952076E17Q40969622-ED7E3932-A624-46FB-A2F8-A1B4B9E6AA4BQ42090608-3BF393E7-A786-4383-8229-9769D8AB11ADQ44732086-9164FF65-53BD-4013-B35A-4F139EAED314Q47122336-91784E51-4625-4FCE-9E29-13B9AE068670Q47448916-9C870DAB-7338-414E-AB90-AF92CB727FB1Q47824028-D4D53001-DBC2-4810-9CA1-FDAFEE0DE349Q49830478-FBE7A45C-2161-42EF-820C-26DF05753B61Q52629687-2817B2BF-5D44-4F60-9302-67ACB2496119Q52658589-8EACC0A6-775E-4E04-897C-9C6F2517C067Q54967145-A3E46C2E-A12D-4DBE-99F7-68FD82F98D19Q54978019-50654F19-3FCE-4857-B58A-66C8D5982216Q55024228-2DAE9CC3-3C31-4901-9AED-B9C2BFF5E4B1Q55176955-AC960E14-2B1C-4914-B421-ACBE457F4856
P2860
MicroRNA-142-3p inhibits hypoxia/reoxygenation‑induced apoptosis and fibrosis of cardiomyocytes by targeting high mobility group box 1.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MicroRNA-142-3p inhibits hypox ...... ing high mobility group box 1.
@en
type
label
MicroRNA-142-3p inhibits hypox ...... ing high mobility group box 1.
@en
prefLabel
MicroRNA-142-3p inhibits hypox ...... ing high mobility group box 1.
@en
P2093
P2860
P356
P1476
MicroRNA-142-3p inhibits hypox ...... ing high mobility group box 1.
@en
P2093
P2860
P304
P356
10.3892/IJMM.2016.2756
P577
2016-09-28T00:00:00Z